Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by skyhigh123on Oct 09, 2018 9:00pm
85 Views
Post# 28770070

RE:Sky high smart investors can look at what you wrote past 12

RE:Sky high smart investors can look at what you wrote past 12 2# Well if I recall we all knew there was no money to do this trial without a partnership imho 
3# yes no agreement there plus an FDA surprise 
4# it was tolerable going from 12 cents to $3.60 in three years then back to 44 cents in three years 
5# You have to have something if someone or a company is going to lend you $200,000,000.00
6# I feel we are turning around the silence is deafening plus the FDA minutes I feel are in our favour (imho) 




Bullboard Posts